Since Benatar et al. study has shown that IL‐25 exerts antitumor function through activation of eosinophils and B cells, it is concluded that injection of recombinant IL‐25 (rIL‐25) might be effective for tumor inhibition. The gene discussed is IL25; the disease is neoplasm.